Savvy Updates 3/24/25: Extension of Special Diabetes Program, Funding Cut to Diabetes Prevention Program (DPP), Sequel Partners & Abbott FreeStyle Libre 3 Plus, Afrezza Lowers A1C, ATTD 2025 on Dexcom 15-day Sensor &Tandem Control-IQ for T2D, Non-Invasive Glucose Monitoring Using Photoacoustic Sensing, Increase in CKD, Cell Therapies for T1D, KDIGO CKD Guidelines, Medtronic InPen Device Issue, Duodenal Mucosal Resurfacing for T1D, Neural Origins of Sugar Cravings

Savvy Updates 3/24/25: Extension of Special Diabetes Program, Funding Cut to Diabetes Prevention Program (DPP), Sequel Partners & Abbott FreeStyle Libre 3 Plus, Afrezza Lowers A1C, ATTD 2025 on Dexcom 15-day Sensor &Tandem Control-IQ for T2D, Non-Invasive Glucose Monitoring Using Photoacoustic Sensing, Increase in CKD, Cell Therapies for T1D, KDIGO CKD Guidelines, Medtronic InPen Device Issue, Duodenal Mucosal Resurfacing for T1D, Neural Origins of Sugar Cravings

Mar 24, 2025 | Advocacy, Diabetes Business, Exercise, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Breakthrough T1D Gratitude for Extension of Special Diabetes Program Funding Cut to Diabetes Prevention Program (DPP) Sequel Partners Integrates with Abbott FreeStyle Libre 3 Plus with Twiist Pump Afrezza Lowers...
Savvy Updates 3/11/24: Sensulin Smart Insulin, Roche CGM, PBMs Not Compliant, Minutia Cell-based Nanosensors, Change Healthcare Hacked, Patient-centered Diabetes Care,

Savvy Updates 3/11/24: Sensulin Smart Insulin, Roche CGM, PBMs Not Compliant, Minutia Cell-based Nanosensors, Change Healthcare Hacked, Patient-centered Diabetes Care,

Mar 11, 2024 | Advocacy, Diabetes Business, Research News

Sensulin’s Biotech Dream Team Is Bringing the Lowest-Cost Smart Insulin to Market by StartUp Health for HealthTransformer.co, 7 March 2024. Sensulin’s idea to create a “smart insulin” (glucose-responsive insulin or “GRI”) is not new. Three of the company’s co-founders...
Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Jun 26, 2023 | Advocacy, Exercise, Featured, Research News, Technology Updates, Videos

Is plant-based, oral insulin within reach for diabetes treatment? by Paul Ian Cross for MedicalNewsToday.com, 21 June 2023.   New research, published in the journal Biomaterials, suggests that a plant-based oral delivery method of proinsulin could...
Skip to content